Compare Unichem Lab with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB TTK HEALTHCARE UNICHEM LAB/
TTK HEALTHCARE
 
P/E (TTM) x -107.0 24.3 - View Chart
P/BV x 0.6 1.7 35.2% View Chart
Dividend Yield % 2.4 0.9 254.9%  

Financials

 UNICHEM LAB   TTK HEALTHCARE
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
TTK HEALTHCARE
Mar-19
UNICHEM LAB/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs2921,215 24.0%   
Low Rs182610 29.8%   
Sales per share (Unadj.) Rs167.7444.4 37.7%  
Earnings per share (Unadj.) Rs-3.617.2 -21.1%  
Cash flow per share (Unadj.) Rs5.927.6 21.5%  
Dividends per share (Unadj.) Rs4.005.00 80.0%  
Dividend yield (eoy) %1.70.5 308.0%  
Book value per share (Unadj.) Rs372.3177.9 209.2%  
Shares outstanding (eoy) m70.3814.13 498.1%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.42.1 68.8%   
Avg P/E ratio x-65.352.9 -123.4%  
P/CF ratio (eoy) x39.933.0 120.8%  
Price / Book Value ratio x0.65.1 12.4%  
Dividend payout %-110.229.0 -380.0%   
Avg Mkt Cap Rs m16,68012,894 129.4%   
No. of employees `0002.62.3 112.5%   
Total wages/salary Rs m2,3931,307 183.1%   
Avg. sales/employee Rs Th4,535.22,715.7 167.0%   
Avg. wages/employee Rs Th919.8565.3 162.7%   
Avg. net profit/employee Rs Th-98.2105.4 -93.2%   
INCOME DATA
Net Sales Rs m11,8016,279 187.9%  
Other income Rs m98478 1,269.8%   
Total revenues Rs m12,7856,356 201.1%   
Gross profit Rs m-835496 -168.5%  
Depreciation Rs m674147 459.2%   
Interest Rs m7534 222.5%   
Profit before tax Rs m-600393 -152.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-343149 -230.7%   
Profit after tax Rs m-256244 -104.9%  
Gross profit margin %-7.17.9 -89.6%  
Effective tax rate %57.337.9 151.0%   
Net profit margin %-2.23.9 -55.8%  
BALANCE SHEET DATA
Current assets Rs m20,3842,717 750.2%   
Current liabilities Rs m5,0291,571 320.2%   
Net working cap to sales %130.118.3 712.7%  
Current ratio x4.11.7 234.3%  
Inventory Days Days10532 325.8%  
Debtors Days Days13547 289.1%  
Net fixed assets Rs m9,023991 910.5%   
Share capital Rs m141141 99.6%   
"Free" reserves Rs m26,0582,373 1,098.1%   
Net worth Rs m26,1992,514 1,042.0%   
Long term debt Rs m03 0.0%   
Total assets Rs m31,4964,158 757.5%  
Interest coverage x-7.012.6 -55.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.41.5 24.8%   
Return on assets %-0.66.7 -8.6%  
Return on equity %-1.09.7 -10.1%  
Return on capital %-2.016.9 -11.8%  
Exports to sales %69.43.6 1,934.6%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs m8,188225 3,635.9%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m8,188225 3,635.9%   
Fx outflow Rs m59671 838.1%   
Net fx Rs m7,592154 4,927.0%   
CASH FLOW
From Operations Rs m-3,278173 -1,893.5%  
From Investments Rs m-2,86097 -2,963.8%  
From Financial Activity Rs m-24-307 7.9%  
Net Cashflow Rs m-4,690-38 12,440.8%  

Share Holding

Indian Promoters % 50.1 65.4 76.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 3.7 408.1%  
FIIs % 3.0 5.2 57.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 25.8 122.9%  
Shareholders   20,176 12,723 158.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SANOFI INDIA  ABBOTT INDIA  FRESENIUS KABI ONCO.  CIPLA  TORRENT PHARMA  

Compare UNICHEM LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Higher; Automobile & Metal Stocks Lead(09:30 am)

Asian share markets are higher today as better-than-expected Apple Inc earnings drove some regional tech gains although broader confidence was capped by worries about the economic.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

How to Buy the Best Safe Stocks in 2020(The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market(Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

The Best Asset Class to Invest in 2020(Fast Profits Daily)

Jan 24, 2020

Why I'm most bullish on this asset class above all else in 2020.

Small is Beautiful in 2020 (A Prediction You Don't Want to Miss)(Profit Hunter)

Jan 17, 2020

As always Apurva will predict the best asset class to invest in in the coming year, last year he predicted gold and he was bang on! And this year he predicts... wait, you have to read to find out! Don't miss this.

The Smallcap Rebound Has Begun (13 Stocks Up Over 20% in the last Month)(Profit Hunter)

Jan 21, 2020

The best smallcap stocks to bet on to get rich in this market rebound.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 29, 2020 11:05 AM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS